EP0677041A4 - Composes chimiques. - Google Patents

Composes chimiques.

Info

Publication number
EP0677041A4
EP0677041A4 EP19940905503 EP94905503A EP0677041A4 EP 0677041 A4 EP0677041 A4 EP 0677041A4 EP 19940905503 EP19940905503 EP 19940905503 EP 94905503 A EP94905503 A EP 94905503A EP 0677041 A4 EP0677041 A4 EP 0677041A4
Authority
EP
European Patent Office
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19940905503
Other languages
German (de)
English (en)
Other versions
EP0677041A1 (fr
Inventor
James Samanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0677041A4 publication Critical patent/EP0677041A4/fr
Publication of EP0677041A1 publication Critical patent/EP0677041A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP94905503A 1992-12-30 1993-12-22 Composes chimiques Withdrawn EP0677041A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US99835692A 1992-12-30 1992-12-30
US998356 1992-12-30
US13890993A 1993-10-18 1993-10-18
US138909 1993-10-18
PCT/US1993/012531 WO1994015913A1 (fr) 1992-12-30 1993-12-22 Composes chimiques

Publications (2)

Publication Number Publication Date
EP0677041A4 true EP0677041A4 (fr) 1995-08-29
EP0677041A1 EP0677041A1 (fr) 1995-10-18

Family

ID=26836680

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94905503A Withdrawn EP0677041A1 (fr) 1992-12-30 1993-12-22 Composes chimiques

Country Status (3)

Country Link
EP (1) EP0677041A1 (fr)
JP (1) JPH08505391A (fr)
WO (1) WO1994015913A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0656348T3 (da) * 1993-12-03 2000-09-11 Hoffmann La Roche Eddikesyrederivater som medikamenter
DE10121003A1 (de) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9415913A1 *

Also Published As

Publication number Publication date
WO1994015913A1 (fr) 1994-07-21
EP0677041A1 (fr) 1995-10-18
JPH08505391A (ja) 1996-06-11

Similar Documents

Publication Publication Date Title
GB9201179D0 (en) Chemical compounds
GB9201180D0 (en) Chemical compounds
GB9201038D0 (en) Chemical compounds
GB9202915D0 (en) Chemical compounds
EP0633771A4 (en) Compounds.
EP0603314A4 (en) Chemical compounds.
GB9207964D0 (en) Chemical compounds
GB9206989D0 (en) Chemical compounds
EP0653937A4 (fr) Composes chimiques.
EP0536310A4 (fr) Composes chimiques.
EP0677041A4 (fr) Composes chimiques.
GB9205136D0 (en) Chemical compounds
EP0684949A4 (fr) Composes chimiques.
GB9205140D0 (en) Chemical compounds
ZA932264B (en) Compounds.
ZA93692B (en) Arylalkoxyphenoxy-imidazoline compounds.
GB9201821D0 (en) Chemical compounds
GB9205879D0 (en) Chemical compounds
GB9204260D0 (en) Chemical compounds
GB9204757D0 (en) Chemical compounds
GB9201176D0 (en) Chemical compounds
GB9201178D0 (en) Chemical compounds
GB9205133D0 (en) Chemical compounds
GB9201052D0 (en) Chemical compounds
GB9201173D0 (en) Chemical compounds

Legal Events

Date Code Title Description
A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE FR GB IT LI NL

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950710

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE FR GB IT LI NL

17Q First examination report despatched

Effective date: 19980525

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19981006